Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Camp4 Therapeutics Corp as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −10 vs. Q1 2025
- Shares held
- 11.7M
- −932.9K (−7.4%) vs. Q1 2025
- Total value
- $17.0M
- −$33.7M (−66.4%) vs. Q1 2025
- New holders
- 7
- 6 more added
- Sold out
- 17
- 11 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CAMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $182.2M |
| Q1 2026 | 46 | $175.5M |
| Q4 2025 | 40 | $234.6M |
| Q3 2025 | 29 | $84.6M |
| Q2 2025 | 29 | $17.0M |
| Q1 2025 | 39 | $50.7M |
| Q4 2024 | 36 | $67.1M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Camp4 Therapeutics Corp; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Enavate Sciences GP, LLC | 3,785,802 | $5.49M | 3.11% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 2,927,915 | $4.25M | 1.63% | 00.0% | Unchanged |
| AH Capital Management, L.L.C. | 2,125,339 | $3.08M | 0.98% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 1,271,948 | $1.84M | 2.02% | 00.0% | Unchanged |
| FMR LLC | 607,946 | $881.5K | 0.00% | −159,001−20.7% | Reduced |
| Vanguard Group Inc | 328,891 | $476.9K | 0.00% | +95,058+40.7% | Added |
| Alyeska Investment Group, L.P. | 200,000 | $290.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 133,036 | $192.9K | 0.00% | +133,036 | New |
| BlackRock, Inc. | 84,221 | $122.1K | 0.00% | −211,995−71.6% | Reduced |
| Victory Capital Management Inc | 83,060 | $120.4K | 0.00% | +1,330+1.6% | Added |
| Geode Capital Management, LLC | 75,199 | $109.0K | 0.00% | −84,403−52.9% | Reduced |
| Goldman Sachs Group Inc | 26,511 | $38.4K | 0.00% | +14,556+121.8% | Added |
| Bridgeway Capital Management, LLC | 25,000 | $36.3K | 0.00% | +25,000 | New |
| Qube Research & Technologies Ltd | 14,871 | $21.6K | 0.00% | +14,871 | New |
| Verition Fund Management LLC | 14,760 | $21.4K | 0.00% | +14,760 | New |
| Northern Trust Corp | 14,615 | $21.2K | 0.00% | −42,324−74.3% | Reduced |
| Cantor Fitzgerald, L. P. | 12,320 | $17.9K | 0.00% | +12,320 | New |
| UBS Group AG | 5,088 | $7.38K | 0.00% | +1,905+59.8% | Added |
| Tower Research Capital LLC (TRC) | 3,830 | $5.55K | 0.00% | +3,830 | New |
| Morgan Stanley | 1,687 | $2.45K | 0.00% | −7,285−81.2% | Reduced |
| Royal Bank of Canada | 953 | $2.00K | 0.00% | +533+126.9% | Added |
| Bank of America Corp | 652 | $946 | 0.00% | −2,612−80.0% | Reduced |
| BNP Paribas Arbitrage, SA | 427 | $619 | 0.00% | +215+101.4% | Added |
| JPMorgan Chase & Co | 238 | $345 | 0.00% | −8,005−97.1% | Reduced |
| Wells Fargo & Company | 119 | $173 | 0.00% | −3,662−96.9% | Reduced |
| Nisa Investment Advisors, LLC | 101 | $146 | 0.00% | −119−54.1% | Reduced |
| SBI Securities Co., Ltd. | 20 | $29 | 0.00% | +20 | New |
| EverSource Wealth Advisors, LLC | 3 | $4 | 0.00% | −13−81.3% | Reduced |
| CWM, LLC | 68 | $0 | 0.00% | −192−73.8% | Reduced |
| Franklin Resources Inc | 0 | $0 | 0.00% | −635,054−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −26,236−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −16,685−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −13,118−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −7,508−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −6,600−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −5,820−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,008−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,643−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −3,786−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −3,487−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −720−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −708−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −542−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −71−100.0% | Sold out |